Between 40% and 45% of COVID-19 infections could be in people who display no symptoms of the illness, according to an analysis by Scripps Research published in Annals of Internal Medicine.

Researchers at Cleveland Clinic have created the first risk prediction model that allows healthcare providers to find the likelihood of an individual patient testing positive for COVID—19, as well as possible outcomes from the virus.

A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.

The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

HHS is distributing another $35 billion from the CARES Act designated for healthcare providers responding to the crisis. The CARES Act allocated $175 billion in relief funds to hospitals and healthcare providers, especially those majorly affected by the pandemic.

HHS has announced new laboratory data reporting guidance for COVID-19 testing, expanding requirements for laboratories to report demographic details that can help improve the public response.

CMS is increasing enforcement, including civil penalties, against nursing homes with persistent infection control violations for COVID-19.